Frontier Capital Management CO LLC Sage Therapeutics, Inc. Transaction History

Frontier Capital Management CO LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Jul 17, 2020	SELL	$25.95 - $43.15 $5.88 Million - $9.78 Million	-226,679 Closed	0 $0
Q1 2020 Apr 16, 2020	SELL	$26.15 - $77.24 $9.99 Million - $29.5 Million	-382,062 Reduced 62.76%	226,679 $6.51 Million
Q4 2019 Feb 14, 2020	BUY	$60.18 - $154.77 $36.4 Million - $93.6 Million	604,867 Added 15613.5%	608,741 $43.9 Million
Q3 2019 Nov 14, 2019	SELL	$140.29 - $189.96 $36 Million - $48.8 Million	-256,851 Reduced 98.51%	3,874 $543,000
Q2 2019 Aug 14, 2019	BUY	$157.85 - $183.09 $291,706 - $338,350	1,848 Added 0.71%	260,725 $47.7 Million

Q1 2019 May 07, 2019	BUY	$89.33 - $163.65 $23.1 Million - $42.4 Million	258,877 New	258,877 $41.2 Million

223

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $645M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

Stay updated on Frontier Capital Management CO LLC with notifications on news.